4//SEC Filing
Revance Therapeutics, Inc. 4
Accession 0001209191-16-118596
CIK 0001479290operating
Filed
May 8, 8:00 PM ET
Accepted
May 9, 7:12 PM ET
Size
5.4 KB
Accession
0001209191-16-118596
Insider Transaction Report
Form 4
PRYGOCKI MARK A SR
Director
Transactions
- Award
Stock Option (Right to Buy)
2016-05-05+8,000→ 8,000 totalExercise: $16.63Exp: 2026-05-04→ Common Stock (8,000 underlying)
Footnotes (1)
- [F1]The shares subject to the stock option shall vest on the one year anniversary of May 5, 2016, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) through such vesting date. The stock option represents an annual option grant pursuant to the Issuer's Non-Employee Director Compensation Policy.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001479290
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 7:12 PM ET
- Size
- 5.4 KB